Navigation Links
Life Technologies Supports Global Effort to Help Accelerate Emergency Screening of Avian Influenza (H7N9) Virus
Date:4/26/2013

equests for assistance with the H1N1 outbreak. 
  • 2011 – Life Technologies developed a custom assay to accurately detect the E. coli bacterium that spread through Europe.  The assay was developed after company researchers, using samples supplied by scientists at University Hospital Munster, completed the DNA sequencing and analysis work on the deadly E. coli strain using the Ion PGM™ Sequencer.    
  • 2012 – Life Technologies established the Global Influenza Network, a partnership of scientists at a number of the world's leading government public health organizations, veterinary agencies and research institutes who collaborate in an effort to increase the speed and efficiency of influenza monitoring and vaccine development. 
  • Today – Life Technologies' Ion PGM™ Sequencer is being used to characterize the genetic sequence of the virus and to determine if it can be transmitted from human to human.
  • "We have learned through our past experiences that a strong surveillance program is crucial in times like these," said Dan Didier , Public Health Director for Life Technologies.  "We are working continually with our partners around the globe on improving our capabilities, particularly when it comes to developing rapid detection
    '/>"/>

    SOURCE Life Technologies Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4

    Related medicine technology :

    1. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
    2. U.S. Patent Office Issues Sixth Patent Covering Zero-Footprint Medical Image Viewers to Heart Imaging Technologies, LLC
    3. Althea Technologies Appoints Dr. Kristin DeFife, Director, Biologics Manufacturing And Jack Wright, VP, Sales and Marketing
    4. BioSpecifics Technologies Corp. Announces Rescheduled First Quarter 2012 Financial Results Conference Call to May 10, 2012
    5. Global Ablation Technologies Market worth $12.4 Billion by 2016: MarketsandMarkets
    6. ICU Medical, Inc. Plans to "Vigorously Seek to Collect Damages" in wake of Patent Infringement Victory Over RyMed Technologies
    7. BioStorage Technologies to Lead Discussion on the Value of a Comprehensive Sample Management Strategy
    8. Global Ablation Technologies Market (2011-2016) - By Application and Devices in Radiofrequency, Cryoablation, Microwave, Ultrasound, Hydrothermal, Radiation, Electrical, Light/Laser and Hydromechanical - Global Trends & Competitive Analysis
    9. MedClean Technologies Announces 2011 Results
    10. Patient Safety Technologies Reports First Quarter 2012 Results
    11. Breathe Technologies Non-Invasive Open Ventilation (NIOV™) System Receives Medical Design Award
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:9/4/2015)... Future Prospects for Companies in Antihistamines, Corticosteroids, ... - new study showing you trends, partnerships, and ... allergic rhinitis drugs heading? What are the commercial prospects ... you potential revenues and other trends to 2025, discussing ... report provides 273 tables, charts, and graphs. Discover the ...
    (Date:9/4/2015)... , Sep. 04, 2015 ... of the "Investigation Report on China,s Sodium Ibandronate Market, ... and used in the clinic under the trade name of ... Austria in 1996, sodium ibandronate was approved by ... treatment of osteoporosis under the trade name of Boniva. However, ...
    (Date:9/4/2015)... September 4, 2015 Hutchison ... that Hutchison MediPharma Limited ("HMP"), its drug R&D ... second proof-of-concept ("POC") trial of fruquintinib in patients ... in China .  The top-line ... meeting the primary efficacy endpoint of progression free ...
    Breaking Medicine Technology:Allergic Rhinitis Drugs Market Forecast 2015-2025 2Allergic Rhinitis Drugs Market Forecast 2015-2025 3Allergic Rhinitis Drugs Market Forecast 2015-2025 4Allergic Rhinitis Drugs Market Forecast 2015-2025 5Allergic Rhinitis Drugs Market Forecast 2015-2025 6Allergic Rhinitis Drugs Market Forecast 2015-2025 7Investigation Report on China's Sodium Ibandronate Market 2010-2019 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 2Second Proof-of-concept Trial of Fruquintinib Achieves its Primary Endpoint 3
    ... Late Stage Clinical Therapeutic Cancer... -- TUEBINGEN, Germany, September 21, 2010 ... ... ... ,; var first_result; // Results are keyed by longUrl, so we need to grab the first one. ...
    ... Inc., today announced that it reported positive preclinical ... Association for the Study of Diabetes (EASD).  CCX140, ... the chemokine receptor CCR2, improved metabolic function while ... in an animal model, and was well tolerated ...
    Cached Medicine Technology:immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 2immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 3immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 4immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 5immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 6immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 7immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 8immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 9immatics Raises EUR54 Million to Advance its Late Stage Clinical Therapeutic Cancer Vaccine Portfolio 10ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 2ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 3ChemoCentryx Reports Positive Results and Completion of Phase I Clinical Studies of Novel CCR2 Antagonist, CCX140, at the European Association for the Study of Diabetes (EASD) 4
    (Date:9/4/2015)... ... 05, 2015 , ... Paradise Valley Community College (PVCC) is proud ... of their work at Paradise Valley Community College. , PVCC Fine and Performing Arts ... The artists will be on hand to meet the public and discuss their work, ...
    (Date:9/4/2015)... ... 2015 , ... With TransCel from Pixel Film Studios users can simulate celluloid ... With TransCel users have full control over camera position and angle within 3D space ... inner color, text, and more. With TransCel the possibilities are endless. , Users have ...
    (Date:9/4/2015)... ... September 04, 2015 , ... Georgia Insurance Advisors, ... a charity effort to provide for the family of Grace, a young local ... restrictive cardiomyopathy often leads to diastolic dysfunction – the inability to adequately move ...
    (Date:9/4/2015)... ... , ... Keeping mold top of mind is important when considering indoor air ... grow anywhere - on carpet, clothing, food, paper, and even in places you can’t ... the home is key to preventing mold growth, which if exposed to can lead ...
    (Date:9/4/2015)... ... September 04, 2015 , ... Bio-Logic Aqua® Research, a fresh ... its only mission and research focus: Water Life Science®. In the current warming ... evaporation is becoming dangerously accelerated. As a result of the global fresh water, ...
    Breaking Medicine News(10 mins):Health News:Paradise Valley Community College Announces Master Ceramic Artists & Exhibit 2Health News:Pixel Film Studios Releases TransCel, a New FCPX Transition 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 2Health News:Georgia Insurance Advisors Inaugurates Charity Drive to Assist the Family of Young Local Girl Diagnosed with an Enlarged Heart 3Health News:September is Mold Awareness Month 2Health News:September is Mold Awareness Month 3Health News:September is Mold Awareness Month 4Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 2Health News:Bio-Logic Aqua® Research Announces Water Life Science and Body Water Evaporation as Research Focus and Mission 3
    ... TUESDAY, Jan. 31 (HealthDay News) -- Experts comparing three leading ... more toxic and expensive than either surgery or a more ... findings were to be presented Tuesday at a meeting in ... Clinical Oncology (ASCO) and focused on prostate cancer. "Research ...
    ... HealthDay Reporter , TUESDAY, Jan. 31 (HealthDay News) -- ... boost survival for men with advanced prostate cancer, studies suggest. ... stopped early to make sure all participants could benefit from ... known as "metastatic castration-resistant prostate cancers" -- tumors that ...
    ... Philadelphia, PA, January 31, 2011 Back problems are ... condition have a significantly greater chance of retiring early ... other health condition. A group of Australian researchers ... immediate income available to these individuals, but it also ...
    ... hygiene could cut the spread of flu-like symptoms up to ... A new report shows the second-year results (2007-2008) of the ... reduction in flu-like illness over the study period when using ... Allison Aiello, associate professor of epidemiology in the U-M School ...
    ... researchers have developed a better way to detect the slight ... type of cancer or other diseases. Their results are ... Angewandte Chemie . This work could advance understanding ... in personalized medicine, which aims to target drugs and other ...
    ... (HealthDay News) -- Using stem cells to create liver-like ... out why people respond differently to hepatitis C infection, ... are resistant to hepatitis C, while others are highly ... inflammation and organ failure. Studying liver cells from ...
    Cached Medicine News:Health News:Study Compares 3 Common Prostate Cancer Treatments 2Health News:Study Compares 3 Common Prostate Cancer Treatments 3Health News:Study Compares 3 Common Prostate Cancer Treatments 4Health News:Experimental Drugs Do Battle Against Advanced Prostate Cancer 2Health News:Experimental Drugs Do Battle Against Advanced Prostate Cancer 3Health News:People who retire early due to back problems face long-term financial disadvantage 2Health News:Pairing masks and hand washing could drastically slow spread of pandemic flu 2Health News:Genes linked to cancer could be easier to detect with liquid lasers 2
    ... 3085 SP Surgical Table provides state-of-the-art voice-activated ... be networked with the HERMES Control Center ... Endoscopy) to allow the surgeon direct control ... uses either simple voice commands or a ...
    ... 3085 SP Surgical Table combines innovation and ... weighing up to 1,000 lbs. You can ... both normal and reverse orientation and have ... other patients.,The Amsco 3085 SP Table offers ...
    The Acumed Great Toe System is a two-piece non-constrained implant for the first MP joint. The system was developed to provide ease of use for the surgeon, combined with precise instrumentation and a...
    ... SCREW SYSTEM for the Orthopedic Foot and ... can be used for small bone osteotomies, ... two simplified screw sizes in one compact ... unique set of instrumentation. These lag ...
    Medicine Products: